Cefuroxime-MIP-1500mg-EE-RA

UnicomIG
0.1.0 - ci-build

UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Cefuroxime-MIP-1500mg-EE-RA

Generated Narrative: RegulatedAuthorization Cefuroxime-MIP-1500mg-EE-RA

identifier: 805813

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#EE-100009199-27834,http://ema.europa.eu/fhir/pmsId#EE0000002; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Powder for solution for injection/infusion; legalStatusOfSupply = Medicinal Product subject to medical prescription; classification = Cefuroxime,cefuroxime

type: Marketing Authorisation

region: Republic of Estonia

status: Valid - Renewed/Varied

statusDate: 2017-12-06

holder: Organization Mip Pharma GmbH

Links: Table of Contents | QA Report

The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.